为您找到相关结果约500个

你是不是要搜索 期刊植入式皮下微量渗透泵ITCA 650 点击跳转

ITCA 650

Evaluation of a New Placement System for ITCA 650

ITCA 650 Improves Glycemic Control and Reduces the Need to Advance Antidiabetes Therapy

ITCA 650: a novel therapeutic approach to treating patients with type 2 diabetes

ITCA 650 improves glycaemic control and reduces the need to advance antidiabetic therapy

ITCA 650 Significantly Reduces the Need to Advance Antidiabetes Therapy Compared with Sitagliptin

Effect of ITCA 650 on the PK of Acetaminophen (APAP) and Other Commonly Coadministered Drugs

Exploring two dose regimens of ITCA 650 to switch from stable liraglutide therapy in patients with type

ITCA 650 exenatide vs sitagliptin added-on to metformin: estimates of the need for further diabetes therapy

Treatment satisfaction with ITCA 650, a novel drug-device delivering continuous exenatide, versus twice-daily

Treatment with ITCA 650 Does Not Affect the Pharmacokinetics (PK) and Pharmacodynamics of a Combination

ITCA 650 provides consistent efficacy in type 2 diabetes irrespective of baseline characteristics: results

Delivery of exenatide by subdermal placement of ITCA 650 in a nonclinical juvenile rabbit model to determine

Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled

Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes

为您找到相关结果约500个

共500条页码: 1/34页15条/页